Close Menu

EUA Now Sought

Pfizer and BioNTech announced that they will be submitting an application for an Emergency Use Authorization for their candidate coronavirus vaccine to the US Food and Drug Administration today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.